Sponsor or institution
Clinical trials and research at CorrectSequence Therapeutics Co., Ltd
As of November 12, 2026, Find a Trial lists 2 clinical trials run by CorrectSequence Therapeutics Co., Ltd that are recruiting, in China. By phase: Early Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
CS-121 APOC3 base-edit gene therapy for familial chylomicronemia (FCS)
This trial will try a single-course, dose-escalation APOC3 base-editing treatment (CS-121) delivered by lipid nanoparticles in adults 18–55 with genetically confirmed FCS and very high triglycerides to see if it lowers ApoC3 and triglycerides and is safe.
-
CS-206 treatment for sickle cell disease
This study is testing a new injection called CS-101 to see if it can safely help people with sickle cell disease by boosting their production of fetal hemoglobin.
Quick answers
How many clinical trials run by CorrectSequence Therapeutics Co., Ltd are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.